The bovine parainfluenza virus type-3 (BPIV-3) hemagglutinin/neuraminidase glycoprotein expressed in baculovirus protects calves against experimental BPIV-3 challenge

Author： Haanes E.J.   Guimond P.   Wardley R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.6, 1997-04, pp. : 730-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to P

By Tao T.   Davoodi F.   Cho C.J.   Skiadopoulos M.H.   Durbin A.P.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1359-1366

Elsevier

Access to resources Recommend Favorite

Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant

By Sinnathamby G.   Renukaradhya G.J.   Rajasekhar M.   Nayak R.   Shaila M.S.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4816-4823

Elsevier

Access to resources Recommend Favorite

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

By Chen Z.   Matsuo K.   Asanuma H.   Takahashi H.   Iwasaki T.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 653-659

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge

By Tao T.   Skiadopoulos M.H.   Durbin A.P.   Davoodi F.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1100-1108

Elsevier

Access to resources Recommend Favorite